Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1986 May;78(5):395–408.

Update in Cancer Chemotherapy: Gastrointestinal Cancer—Colorectal Cancer, Part 2

Jane C Wright
PMCID: PMC2571349  PMID: 3519988

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of gastrointestinal tract cancer is described in a multi-part series. Part 1 surveyed colorectal cancer and the use of single-agent chemotherapy in the April issue of the Journal. Part 2 of colorectal cancer will describe combination chemotherapy, preoperative and postoperative radiation, and combinations of chemotherapy and radiation, and adjuvant chemotherapy.

In advanced gastrointestinal tract cancer, chemotherapy is only of palliative value with response rates generally under 50 percent and survival rates of several months to one year or more. Combination chemotherapy often produces higher response rates, yet there is no acceptable evidence that survival is improved. While some adjuvant chemotherapy trials suggest improvement, major survival gains remain to be demonstrated. Uncertainty as to the role of chemotherapy in the treatment of gastrointestinal cancers may be due to lack of data.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker L. H., Talley R. W., Matter R., Lehane D. E., Ruffner B. W., Jones S. E., Morrison F. S., Stephens R. L., Gehan E. A., Vaitkevicius V. K. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. Cancer. 1976 Jul;38(1):1–7. doi: 10.1002/1097-0142(197607)38:1<1::aid-cncr2820380102>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  2. Baker L. H., Vaitkevicius V. K., Gehan E. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Cancer Treat Rep. 1976 Jun;60(6):733–737. [PubMed] [Google Scholar]
  3. Benz C., Cadman E. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer Res. 1981 Mar;41(3):994–999. [PubMed] [Google Scholar]
  4. Bertino J. R., Sawicki W. L., Lindquist C. A., Gupta V. S. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res. 1977 Jan;37(1):327–328. [PubMed] [Google Scholar]
  5. Budman D. R., Schulman P., Vinciguerra V., Degnan T. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma. Cancer Treat Rep. 1981 May-Jun;65(5-6):535–535. [PubMed] [Google Scholar]
  6. Buroker T. R., Nigro N., Bradley G., Pelok L., Chomchai C., Considine B., Vaitkevicius V. K. Combined therapy for cancer of the anal canal: a follow-up report. Dis Colon Rectum. 1977 Nov-Dec;20(8):677–678. doi: 10.1007/BF02586688. [DOI] [PubMed] [Google Scholar]
  7. Butoker T., Nigro N., Correa J., Vaitkevigius V. K., Samson M., Considine B. Combination preoperative radiation and chemotherapy in adenocarcinoma of the rectum: preliminary report. Dis Colon Rectum. 1976 Nov-Dec;19(8):660–663. doi: 10.1007/BF02591003. [DOI] [PubMed] [Google Scholar]
  8. Byfield J. E., Barone R., Mendelsohn J., Frankel S., Quinol L., Sharp T., Seagren S. Infusional 5-fluorouracil and X-ray therapy for non-resectable esophageal cancer. Cancer. 1980 Feb 15;45(4):703–708. doi: 10.1002/1097-0142(19800215)45:4<703::aid-cncr2820450415>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  9. Cantrell J. E., Jr, Brunet R., Lagarde C., Schein P. S., Smith F. P. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer. Cancer Treat Rep. 1982 Jul;66(7):1563–1565. [PubMed] [Google Scholar]
  10. DeCosse J. J. Are we doing better with large-bowel cancer? N Engl J Med. 1984 Mar 22;310(12):782–783. doi: 10.1056/NEJM198403223101209. [DOI] [PubMed] [Google Scholar]
  11. Dixon W. J., Longmire W. P., Jr, Holden W. D. Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten-year follow-up. Ann Surg. 1971 Jan;173(1):26–39. doi: 10.1097/00000658-197101000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dwight R. W., Humphrey E. W., Higgins G. A., Keehn R. J. FUDR as an adjuvant to surgery in cancer of the large bowel. J Surg Oncol. 1973;5(3):243–249. doi: 10.1002/jso.2930050307. [DOI] [PubMed] [Google Scholar]
  13. Engstrom P. F., MacIntyre J. M., Douglass H. O., Jr, Muggia F., Mittelman A. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275). Cancer. 1982 Apr 15;49(8):1555–1560. doi: 10.1002/1097-0142(19820415)49:8<1555::aid-cncr2820490807>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  14. Falkson G., van Eden E. B., Falkson H. C. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer. Cancer. 1974 May;33(5):1207–1209. doi: 10.1002/1097-0142(197405)33:5<1207::aid-cncr2820330502>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  15. Gewirtz A. M., Cadman E. Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer. 1981 Jun 1;47(11):2552–2555. doi: 10.1002/1097-0142(19810601)47:11<2552::aid-cncr2820471106>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  16. Gilbert J. M., Hellmann K., Evans M., Cassell P. G., Stoodley B., Ellis H., Wastell C. Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer. Cancer Chemother Pharmacol. 1982;8(3):293–299. doi: 10.1007/BF00254053. [DOI] [PubMed] [Google Scholar]
  17. Goldie J. H., Coldman A. J., Gudauskas G. A. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 1982 Mar;66(3):439–449. [PubMed] [Google Scholar]
  18. Grossi C. E., Wolff W. I., Nealon T. F., Jr, Pasternack B., Ginzburg L., Rousselot L. M. Intraluminal fluorouracil chemotherapy adjunct to surgical procedures for respectable carcinoma of the colon and rectum. Surg Gynecol Obstet. 1977 Oct;145(4):549–554. [PubMed] [Google Scholar]
  19. Gunderson L. L. Combined irradiation and surgery for rectal and sigmoid carcinoma. Curr Probl Cancer. 1976 Nov;1(5):40–53. doi: 10.1016/s0147-0272(76)80005-0. [DOI] [PubMed] [Google Scholar]
  20. Gunderson L. L., Shipley W. U., Suit H. D., Epp E. R., Nardi G., Wood W., Cohen A., Nelson J., Battit G., Biggs P. J. Intraoperative irradiation: a pilot study combining external beam photons with "boost" dose intraoperative electrons. Cancer. 1982 Jun 1;49(11):2259–2266. doi: 10.1002/1097-0142(19820601)49:11<2259::aid-cncr2820491110>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  21. Herrmann R., Manegold C., Holzmann K., Fritze D. Sequentielle Verabreichung von Methotrexat und Fluorouracil bei metastasierenden kolorektalen Karzinomen. Ergebnisse einer Phase-II-Pilotstudie. Dtsch Med Wochenschr. 1982 Apr 2;107(13):491–493. doi: 10.1055/s-2008-1069961. [DOI] [PubMed] [Google Scholar]
  22. Herrmann R., Spehn J., Beyer J. H., von Franqué U., Schmieder A., Holzmann K., Abel U. Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer. J Clin Oncol. 1984 Jun;2(6):591–594. doi: 10.1200/JCO.1984.2.6.591. [DOI] [PubMed] [Google Scholar]
  23. Herrmann R., Spehn J., Beyer J. H., von Franqué U., Schmieder A., Holzmann K., Abel U. Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer. J Clin Oncol. 1984 Jun;2(6):591–594. doi: 10.1200/JCO.1984.2.6.591. [DOI] [PubMed] [Google Scholar]
  24. Higgins G. A., Humphrey E., Juler G., LeVeen H. H., McCaughan J., Keehn R. J. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer. 1976 Oct;38(4):1461–1467. doi: 10.1002/1097-0142(197610)38:4<1461::aid-cncr2820380402>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  25. Higgins G. A., Jr, Amadeo J. H., McElhinney J., McCaughan J. J., Keehn R. J. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report. Cancer. 1984 Jan 1;53(1):1–8. doi: 10.1002/1097-0142(19840101)53:1<1::aid-cncr2820530102>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  26. Kemeny N. E., Ahmed T., Michaelson R. A., Harper H. D., Yip L. C. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate. J Clin Oncol. 1984 Apr;2(4):311–315. doi: 10.1200/JCO.1984.2.4.311. [DOI] [PubMed] [Google Scholar]
  27. Kemeny N., Yagoda A., Braun D., Jr, Golbey R. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep). Cancer. 1980 Mar 1;45(5):876–881. doi: 10.1002/1097-0142(19800301)45:5<876::aid-cncr2820450509>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  28. Klein H. O., Wickramanayake P. D., Dieterle F., Mohr R., Oerkermann H., Brock J., Beyer D., Gross R. Chemotherapieprotokoll zur Behandlung des metastasierenden Magenkarzinoms. Methotrexat, Adriamycin und 5-Fluorouracil. Dtsch Med Wochenschr. 1982 Nov 12;107(45):1708–1712. doi: 10.1055/s-2008-1070192. [DOI] [PubMed] [Google Scholar]
  29. Krauss S., Sonoda T., Solomon A. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C. Cancer. 1979 May;43(5):1598–1603. doi: 10.1002/1097-0142(197905)43:5<1598::aid-cncr2820430505>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  30. Lawrence W., Jr, Terz J. J., Horsley S., 3rd, Donaldson M., Lovett W. L., Brown P. W., Ruffner B. W., Regelson W. Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg. 1975 May;181(5):616–623. doi: 10.1097/00000658-197505000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Li M. C., Ross S. T. Chemoprophylaxis for patients with colorectal cancer. Prospective study with five-year follow-up. JAMA. 1976 Jun 28;235(26):2825–2828. [PubMed] [Google Scholar]
  32. Lokich J. J., Ellenberg S., Gerson B. Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels. J Clin Oncol. 1984 Mar;2(3):181–186. doi: 10.1200/JCO.1984.2.3.181. [DOI] [PubMed] [Google Scholar]
  33. Machover D., Schwarzenberg L., Goldschmidt E., Tourani J. M., Michalski B., Hayat M., Dorval T., Misset J. L., Jasmin C., Maral R. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep. 1982 Oct;66(10):1803–1807. [PubMed] [Google Scholar]
  34. Madajewicz S., Petrelli N., Rustum Y. M., Campbell J., Herrera L., Mittelman A., Perry A., Creaven P. J. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res. 1984 Oct;44(10):4667–4669. [PubMed] [Google Scholar]
  35. Michaelson R. A., Magill G. B., Quan S. H., Leaming R. H., Nikrui M., Stearns M. W. Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer. 1983 Feb 1;51(3):390–395. doi: 10.1002/1097-0142(19830201)51:3<390::aid-cncr2820510306>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  36. Moertel C. G. Chemotherapy of gastrointestinal cancer. N Engl J Med. 1978 Nov 9;299(19):1049–1052. doi: 10.1056/NEJM197811092991906. [DOI] [PubMed] [Google Scholar]
  37. Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst. 1975 Jan;54(1):69–71. doi: 10.1093/jnci/54.1.69. [DOI] [PubMed] [Google Scholar]
  38. Mohiuddin M., Dobelbower R. R., Turalba C., Kramer S., Marks G. A selective sandwich technique of adjuvant radiotherapy in the treatment of rectal cancer: a preliminary experience. Dis Colon Rectum. 1979 Jan-Feb;22(1):1–4. doi: 10.1007/BF02586746. [DOI] [PubMed] [Google Scholar]
  39. Nigro N. D., Vaitkevicius V. K., Considine B., Jr Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974 May-Jun;17(3):354–356. doi: 10.1007/BF02586980. [DOI] [PubMed] [Google Scholar]
  40. Rider W. D., Palmer J. A., Mahoney L. J., Robertson C. T. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg. 1977 Jul;20(4):335–338. [PubMed] [Google Scholar]
  41. Romsdahl M. M., Withers H. R. Radiotherapy combined with curative surgery. Its use as therapy for carcinoma of the sigmoid colon and rectum. Arch Surg. 1978 Apr;113(4):446–453. doi: 10.1001/archsurg.1978.01370160104017. [DOI] [PubMed] [Google Scholar]
  42. Roswit B., Higgins G. A., Humphrey E. W., Robinette C. D. Preoperative irradiation of operable adenocarcinoma of the rectum and rectosigmoid colon. Radiology. 1973 Aug;108(2):389–395. doi: 10.1148/108.2.389. [DOI] [PubMed] [Google Scholar]
  43. STEARNS M. W., Jr, BERG J. W., DEDDISH M. R. Preoperative irradiation of cancer of the rectum. Dis Colon Rectum. 1961 Nov-Dec;4:403–408. doi: 10.1007/BF02616572. [DOI] [PubMed] [Google Scholar]
  44. Schabel F. M., Jr Concepts for systemic treatment of micrometastases. Cancer. 1975 Jan;35(1):15–24. doi: 10.1002/1097-0142(197501)35:1<15::aid-cncr2820350104>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  45. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  46. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  47. Seifert P., Baker L. H., Reed M. L., Vaitkevicius V. K. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer. 1975 Jul;36(1):123–128. doi: 10.1002/1097-0142(197507)36:1<123::aid-cncr2820360108>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  48. Sischy B., Remington J. H., Sobel S. H., Savlov E. D. Treatment of carcinoma of the rectum and squamous carcinoma of the anus by combination chemotherapy, radiotherapy and operation. Surg Gynecol Obstet. 1980 Sep;151(3):369–371. [PubMed] [Google Scholar]
  49. Sischy B. The place of radiotherapy in the management of rectal adenocarcinoma. Cancer. 1982 Dec 1;50(11 Suppl):2631–2637. [PubMed] [Google Scholar]
  50. Solan A., Vogl S. E., Kaplan B. H., Berenzweig M., Richard J., Lanham R. Sequential chemotherapy of advanced colorectal cancer with standard or high-dose methotrexate followed by 5-fluorouracil. Med Pediatr Oncol. 1982;10(2):145–149. doi: 10.1002/mpo.2950100205. [DOI] [PubMed] [Google Scholar]
  51. Stearns M. W., Jr, Deddish M. R., Quan S. H., Leaming R. H. Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet. 1974 Apr;138(4):584–586. [PubMed] [Google Scholar]
  52. Stevens K. R., Jr, Allen C. V., Fletcher W. S. Preoperative radiotherapy for adenocarcinoma of the rectosigmoid. Cancer. 1976 Jun;37(6):2866–2874. doi: 10.1002/1097-0142(197606)37:6<2866::aid-cncr2820370644>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  53. Taylor I., Rowling J., West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg. 1979 Dec;66(12):833–837. doi: 10.1002/bjs.1800661202. [DOI] [PubMed] [Google Scholar]
  54. Taylor S. G., 4th, Desai S. A., DeWys W. D. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma. Cancer Treat Rep. 1978 Aug;62(8):1203–1205. [PubMed] [Google Scholar]
  55. Tisman G., Wu S. J. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):829–835. [PubMed] [Google Scholar]
  56. Warr D., McKinney S., Tannock I. Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol. 1984 Sep;2(9):1040–1046. doi: 10.1200/JCO.1984.2.9.1040. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES